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ABSTRACT 
 
The Impacts on Broiler Performance and Yield by Removing Antibiotic Growth 
Promoters and an Evaluation of Potential Alternatives. (December 2008) 
Joey L. Bray, B.S., Stephen F. Austin State University; 
M.S., Stephen F. Austin State University 
Chair of Advisory Committee: Dr. John B. Carey 
 
Three experiments were conducted to evaluate the impacts of removing antibiotic 
growth promoters (AGP) on broiler performance and yield and to evaluate alternative 
products as potential replacements. In experiment one, approximately 552,000 broilers 
were reared in four solid-wall, tunnel ventilated houses that were divided into two 
paired-house facilities, each assigned one of two dietary treatments. The treated group 
received basal diets containing salinomycin (SAL), roxarsone (ROX) and AGP, while 
the control group received the same diets without ROX and AGP. Removal of ROX and 
AGP had no affect on average body weight and feed efficiency, while livability was 
significantly affected negatively by the removal of ROX and AGP. Tender, wing, drum 
and percentage of total white meat showed significant improvements in yield during the 
study, while all other parts were not affected by removal of ROX and AGP.  
In experiment two, an investigation was conducted to evaluate the effects on 
performance from feeding Bacillus subtilis spores (Gallipro®, Chr Hansen A/S, 
Denmark), as a direct-fed microbial additive, to commercial broiler chickens. Birds were 
 iv 
divided among two paired-house facilities. The treatment group received basal diets 
supplemented with B. subtilis spores, while the control group was fed the same basal 
diets containing an AGP. Feed conversion ratio was significantly lower for the treatment 
group, while average body weight, coccidiosis lesion scores, and footpad scores were not 
affected by the treatments.  
In experiment three, 6,000 broiler chickens were equally divided among four 
treatment groups and reared to 49 d to determine the effectiveness mannan 
oligosaccharides (MOS, Bio-Mos®, Alltech, Nicholasville, Kentucky, USA) as an 
alternative for an AGP program and MOS plus Natustat™ (NAT, Alltech, Nicholasville, 
Kentucky, USA) as an alternative to an enteric health program (AGP+anticoccidial 
drug). Average body weight for the control (CON) and antibiotic (ANT) groups was 
significantly different from the MOS+NAT group, but not the MOS group. Carcass front 
half, carcass hind half, frame and skin yields were improved for all treatments when 
compared to the MOS+NAT group. Conversely, percent total white meat yield was 
improved with the inclusion of MOS when compared to the ANT group. 
The findings of this research suggest that the removal of AGP from the diets of 
commercial broiler chickens does not affect the performance and yield of the birds over 
a one year production period. Furthermore, B. subtilis spores and mannan 
oligosaccharides provide acceptable alternatives to an AGP program. 
 v 
DEDICATION 
 
This dissertation is dedicated to my family, wife Cathryn, daughter Madilyn and 
son Blake. Your love, support, and patience have helped make this possible and your 
dedication to my success was an inspiration. Also, to my mother, Joye, who always 
stood beside me and encouraged me to always reach my full potential. Thank you for all 
of your love and support throughout this process. 
 vi 
ACKNOWLEDGEMENTS 
 
I would like to thank Dr. John B. Carey, my major professor, for his continuous 
guidance and wisdom throughout the course of my studies, for without your help this 
would not have been possible. Your assistance during my studies, research projects, and 
preparation of my dissertation were vital and I thank you.  
 I would like to thank my committee members, Dr. David Caldwell, Dr. Michael 
Davis, and Dr. Morgan Farnell, for their guidance and support in my education and 
research. You all have made a lasting impression on my career and my life, and for that I 
thank you. 
Deep and heartfelt thanks to Dr. Tim Cherry, at Stephen F. Austin State 
University, for your encouragement to continue my education. Your guidance and 
support was a tremendous help. Your wisdom and devotion to my success is greatly 
appreciated. 
Thanks also go to my friends and colleagues that helped make this research 
possible: Crystal Taylor, Danny Rossow, Robert Kavanaugh, Jason Shipp, Pieter Post, 
and all of the students that helped with the numerous yield studies. 
 vii 
TABLE OF CONTENTS 
 
              Page 
ABSTRACT ..............................................................................................................  iii 
DEDICATION ..........................................................................................................  v 
ACKNOWLEDGEMENTS ......................................................................................  vi 
TABLE OF CONTENTS ..........................................................................................  vii 
LIST OF FIGURES...................................................................................................  x 
LIST OF TABLES ....................................................................................................  xi 
CHAPTER 
 I INTRODUCTION................................................................................  1 
  Background ....................................................................................  1 
   Enteric Disease .........................................................................  1 
   Disease Prevention Factors ......................................................  2 
   Brief History of Antibiotic Growth Promoters (AGP).............  3 
   Biological Aspects of AGP ......................................................  4 
   AGP-associated Problems and Concerns .................................  4 
   Banning of AGP Use in the European Union (EU) .................  5 
   AGP Usage in the United States ..............................................  6 
   Search for AGP Alternatives....................................................  6 
   Objectives of the Study ............................................................  9 
 
 II REVIEW OF LITERATURE...............................................................  10 
   Consequences of AGP Removal ....................................................  10 
    Probiotics..................................................................................  12 
    Prebiotics ..................................................................................  13 
    Competitive Exclusion Concept...............................................  14 
    Organic Acids...........................................................................  16 
    Plant Extracts............................................................................  16 
 
  
  
 viii 
CHAPTER                                                                                                                   Page 
 
 III PERFORMANCE COMPARISON BETWEEN THE USE AND  
  NON-USE OF AN ENTERIC HEALTH MEDICTION PROGRAM  
  OVER FIVE CONSECUTIVE COMMERICAL BROILER FLOCK  18 
   
   Introduction ....................................................................................  18 
   Materials and Methods ...................................................................  20 
    Animals and Housing ...............................................................  20 
    Feeding and Dietary Treatments ..............................................  20 
    Yield Study and Data ...............................................................  21 
    Data Collected ..........................................................................  22 
   Results and Discussion...................................................................  23 
    Growth Performance ................................................................  23 
    Coccidiosis Lesion Scores........................................................  26 
    Yield Performance....................................................................  27 
   
 IV EFFICACY OF BACILLUS SUBTILIS SPORES (Gallipro®) ON 
PERFORMANCE OF COMMERICAL BROILER CHICKENS .......  31 
   
   Introduction ....................................................................................  31 
   Materials and Methods ...................................................................  33 
    Animals and Housing ...............................................................  33 
    Feeding and Dietary Treatments ..............................................  34 
    Floor Pen Data..........................................................................  34 
    Data Collected ..........................................................................  35 
   Results and Discussion...................................................................  35 
    Floor Pen Data..........................................................................  35 
    Commercial Paired-house Facility Data ..................................  38 
 
 V EFFICACY STUDY OF SUPLEMENTING Bio-Mos® AND  
  Naustat™ FOR ANTIBIOTIC GROWTH PROMOTERS ON  
  BROILER PERFORMANCE AND YIELD........................................  40 
   
   Introduction ....................................................................................  40 
   Materials and Methods ...................................................................  43 
    Animals and Housing ...............................................................  43 
    Feeding and Dietary Treatments ..............................................  43 
    Yield Study and Data ...............................................................  44 
    Data Collected ..........................................................................  45 
   Results and Discussion...................................................................  45 
    Performance Data .....................................................................  45 
    Yield Data ................................................................................  46 
 
 ix
CHAPTER                                                                                                                   Page 
  
 VI SUMMARY AND CONCLUSIONS...................................................  49 
    
REFERENCES..........................................................................................................  51 
VITA .........................................................................................................................  59 
 x
LIST OF FIGURES 
 
FIGURE                                                                                                                        Page 
 1 Correlation of coccidiosis lesion scores between treatment groups  
  from flock to flock......................................................................................  27 
 
 2 Treatment effect on average body weight of floor pen birds for growth  
  days 18, 35 and 48......................................................................................  36 
 
 3 Treatment effect on feed conversion of floor pen birds for growth days  
  18, 35 and 48 ..............................................................................................  37 
 
 
 
 
 xi
LIST OF TABLES 
 
TABLE                                                                                                                          Page 
 
 1 Ideal characteristics of probiotics and prebiotics .......................................  8 
 
 2 The effect of removing growth-promoting antibiotics (GPA) and  
  roxarsone (ROX) on average bodyweight of broilers at 18, 35 and 
  48 d of age ..................................................................................................  23 
 
 3 The effect of removing growth-promoting antibiotics (GPA) and  
  roxarsone (ROX) on average bodyweight, feed conversion and  
  adjusted feed conversion of broilers at 49 d of age....................................  25 
 
 4 The effect of removing growth-promoting antibiotics (GPA) and  
  roxarsone (ROX) on broiler livability (%) and condemnation (%) at  
  49 d of age ..................................................................................................  26 
 
 5 The effect of removing growth-promoting antibiotics (GPA) and  
  roxarsone (ROX) on breast fillet, tender, and wing yield of broilers at  
  49 d of age ..................................................................................................  29 
 
 6 The effect of removing growth-promoting antibiotics (GPA) and  
  roxarsone (ROX) on total white meat and percentage total white  
  meat yield of broilers at 49 d of age...........................................................  29 
 
 7 The effect of B. subtilis spores and an antibiotic growth promoter  
  program on performance parameters of commercial broiler chickens  
  in paired-house facilities1 at 48 d of age ....................................................  39 
 
 8 Effects of antibiotic growth-promoters, Bio-Mos®, and Natustat™ on  
  BW, FCR, mortality-adjusted FCR, and mortality of broilers at  
  49 d of age ..................................................................................................  46 
 
 9 Treatment effects of antibiotic growth-promoters, Bio-Mos®, and  
  Natustat™ on wing, breast, tender, frame, and skin yield of broilers at  
  49 d of age ..................................................................................................  47 
 
 10 Treatment effects of antibiotic growth-promoters, Bio-Mos®, and  
  Natustat™ on drum, thigh, back, and abdominal fat yield of broilers at  
  49 d of age ..................................................................................................  47 
 
 xii
TABLE                                                                                                                         Page 
 
11 Treatment effects of antibiotic growth-promoters, Bio-Mos®, and  
 Natustat™ on carcass, front half, hind half, total white meat, and  
 percent total white meat yield of broilers at 49 d of age ............................  48 
 1 
CHAPTER I 
INTRODUCTION 
Background 
 Recently, consumers of animal protein products have taken an interest in the 
animal agriculture practices used to meet the demands of producing these products. 
Particular attention has been placed on the health issues of the animals and the intense 
nature of the production systems. Commercial poultry production has been under 
tremendous scrutiny due to its dependence on chemotherapy to improve weight gain and 
feed efficiency, while avoiding enteric health problems common to confined animal 
feeding operations.     
Enteric Disease 
 Disease can be defined as any deviation or interruption of the normal structure or 
function of any part, organ or system within the host [1]. Enteric diseases are detrimental 
to poultry production due to the loss of productivity, increase in mortality, the potential 
for human health risks associated with food borne illness, and the increase in cost 
associated with disease prevention and treatment [2]. Pathogenic microorganisms have 
to elude many natural defenses of the host to cause disease. Low gastric pH, rapid transit 
through portions of the gastrointestinal tract, competitive intestinal microbiota, and 
immune defenses are in place to deny pathogenic microorganisms from colonizing the 
digestive tract and establishing disease. Factors such as stress, nutrition, and injury can 
leave the host more susceptible to disease. The severity and duration of stress factors,  
____________ 
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such as suboptimal temperatures, poor environmental conditions, and improper handling 
can influence the host’s vulnerability to disease. Disease may also result from deficiency 
of vital nutrients or the ingestion of toxic substances from the feed. Nutritional 
deficiencies can lead to improper function of some natural defenses providing optimal 
conditions for the establishment of disease. While some nutritional deficiencies may be 
reversible with supplementation of adequate nutrients, others are irreversible and leave 
the animal permanently disease prone. Injury, whether temporary or permanent, can lead 
to primary and secondary infections that result in disease [3]. 
Disease Prevention Factors 
  Many management factors have an influence on disease control and prevention. 
Biosecurity practices are designed to prevent the spread of disease. Most poultry 
producers have adopted the practice of removing entire flocks from farms before any 
new replacements are added. This “all-in, all-out” concept decreases the spread of 
disease from one flock to the next. Furthermore, young poultry that is more disease-
sensitive is reared in isolation from older poultry that is more disease-resistant. Poultry 
housing and environmental factors can influence the instance of disease. Modern poultry 
facilities have been constructed to minimize conditions conducive for harboring disease 
organisms. Advancements in ventilation have lead to a reduction of stressful conditions 
such as excess dust, high levels of ammonia, damp litter, and excessive draft over the 
birds. Advancements in poultry housing equipment has allowed for more favorable 
conditions. One example is the creation and adoption of the nipple drinking system. 
These drinking systems, when properly used, can decrease the amount of moisture being 
 3 
placed into the litter. Sanitation, mortality disposal, vaccination programs, and rodent 
control are other critical practices that must be addressed for proper biosecurity. While 
biosecurity practices are important in disease prevention, it cannot provide total 
protection against infection. To eliminate the threat of enteric disease and to promote the 
growth of the birds, producers have relied on the use of antibiotics at subtherapeutic 
levels. 
Brief History of Antibiotic Growth Promoters (AGP) 
  During the 1940's, advancements made in poultry genetics, nutrition, housing, 
and marketing fueled the expansion of the US poultry industry [4]. Poultry production 
became more of an intensive and confined production system in order to efficiently 
produce more birds in a shorter period of time. Along with increased production, came 
an increase in the occurrence of disease. During this time period, it was observed that 
animals fed dried mycelia of Streptomyces aureofaciens showed an increase in growth 
[5]. It was later discovered that the dried mycelia contained residues of 
chlorotetracycline, an effective broad spectrum antibiotic. Chlorotetracycline was the 
first of the tetracycline antibiotics. Moore and colleagues [6] were the first to 
demonstrate the beneficial effects of feeding antibiotics at subtherapeutic levels to 
improve performance in poultry. Streptothricin, streptomycin, sulfasuxidine or a 
combination of streptomycin and sulfasuxidine did not sterilize the intestinal tract of 
chickens, but showed a reduction of coliform bacteria in the ceca, while the combination 
of streptomycin and sulfasuxidine increased growth rates of the birds. In 1951, the 
United States Food and Drug Administration (FDA) approved the use of antibiotics as an 
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animal feed additive without the prescription of a veterinarian [4]. The industry quickly 
adopted the use of antibiotic growth promoters and made it the industry standard for 
production.  
Biological Aspects of AGP 
 Antibiotics fed at sub-therapeutic levels promote growth and feed efficiency in 
poultry and other animals [7]. The mechanism of action for AGP has been explained as 
an interaction between the antibiotics and the intestinal microbial population [5]. Four 
major mechanisms of action for AGP have been reviewed to explain their beneficial 
effects on performance [7, 8, 9] These mechanism consist of the following: 1) AGP 
inhibit endemic subclinical infection, thus reducing the metabolic cost of the innate 
immune system; 2) AGP reduce the growth-depressing metabolites produced by 
microbes, such as ammonia and bile degradation products; 3) AGP reduce microbial use 
of nutrients; and 4) AGP enhance the uptake and use of nutrients, due to the thinning of 
the intestinal wall in AGP-fed animals [10]. These mechanisms suggest that, either 
directly or indirectly, the intestinal microflora depresses the growth of the animal. The 
reduction of intestinal microbial population could be the underlying beneficial action of 
AGP. 
AGP-associated Problems and Concerns 
   For over 60 years, the US poultry industry has relied on the use of 
chemoprophylaxis with antibiotics, for the control and prevention of enteric diseases. 
Potential problems and concerns have resulted in global changes for the use of AGP, 
with the most drastic changes occurring in the European Union. One potential problem is 
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the increased resistance of pathogenic bacteria to the approved antibiotics used for 
growth promotion [11]. An early sign of resistance to streptomycin in turkeys was 
reported shortly after the approval of AGP use by the FDA [12]. Tetracycline resistance 
was associated with feeding growth-promoting levels to chickens in the late 1950’s [13, 
14]. By the 1980’s, resistance to numerous antimicrobial agents by pathogenic bacteria 
was reported worldwide [15]. The occurrence of AGP-associated resistant bacteria has 
lead to concerns of human health risks. The possibility of zoonotic bacteria with 
antibiotic resistance linked to animal use of AGP that could be contracted by human 
recipients has stimulated change [11]. The major driving force of these changes has been 
the pressure placed on the poultry industry by consumers of animal meat proteins that 
perceive AGP-associated human health risks to be serious [16]. This consumer pressure 
has lead to major retailers and restaurant chains compelling poultry producers to 
voluntarily reduce the use of AGP.   
Banning of AGP use in the European Union (EU) 
 In 1986, Sweden was the first country to ban the use of antimicrobials for 
growth-promoting purposes [15]. In 1995, Denmark banned the use of Avoparcin (a 
vancomycin-like compound) from use as an AGP in food animals due to reports of 
resistance in isolates from conventional and organic poultry farms. In 1997, the 
Commission of the EU banned Avoparcin in all EU member states [7]. After the banning 
of Avoparcin, the EU Commission launched an investigation into the use of all AGP 
approved for use in their member states. It was determined that the use of AGP could 
increase the instance of microbes with resistant genes and pose a potential for humans if 
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they are transferred to persons. Therefore, the World Health Organization and the 
Economic and Social Commission of the EU concluded that the use of antimicrobials in 
food animals is a public health concern. From this conclusion, a plan was set forth to 
withdraw the use of all remaining approved AGP from all EU member states by January 
1, 2006 [5].  
 AGP Usage in the United States 
 Little regulatory activity has taken place in the US with the use of AGP [7]. In 
2005, fluoroquinolones were banned from use in poultry production in the US [16]. The 
similarity of fluoroquinolones to drugs used in human medicine has lead to their removal 
for therapeutic use. The use of AGP is under tremendous scrutiny in the US, the pressure 
applied by the consumers of animal protein products remains as the major influence of 
voluntary AGP removal. 
Search for AGP Alternatives 
  The mandatory removal of AGP in the EU and the voluntary removal of these 
drugs in the US have resulted in a worldwide search for suitable alternatives to counter 
the expected decline in poultry performance. Some potential alternatives that have been 
tested include probiotics, prebiotics, competitive exclusion cultures, organic acids, and 
plant extracts. Probiotics are defined as a live microbial feed supplement which 
beneficially affects the host animal by improving its intestinal balance [17]. These 
products can be comprised of a single bacteria strain or a mixture of strains. Prebiotics 
are defined as a nondigestible food ingredient that beneficially affects the host by 
selectively stimulating the growth and/or activity of one or a limited number of intestinal 
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bacteria [18]. Both probiotics and prebiotics have ideal characteristics which are shown 
in Table 1. Several microbial strains have been tested for use as probiotics in food 
animals, including species of Bacillus, Bifidobacterium, Enterococcus, E. coli, 
Lactobacillus, Lactococcus, Streptococcus, and varieties of yeast species. Each has 
unique characteristics that make them suitable for use as probiotics. Prebiotics that have 
been tested for animal use include the oligosaccharides (fructo-, trans-galacto-, gluco-, 
glyco-, malto-, xylo-, and sucrose thermal), lactulose, and lactitol [2]. These 
nondigestible ingredients can be fermented by the intestinal microflora and utilized as 
nutrients, decreasing the competition for nutrients between the microbial population and 
the intestinal tract. Competitive exclusion (CE) cultures are defined as mixtures of adult 
intestinal microflora exhibiting disease resistance. Newly-hatched chicks are inoculated 
with this disease resistant adult intestinal microflora to provide protection. Also known 
as the Nurmi-concept, this practice can provide immediate protection to young chicks 
that are prone to disease without an established intestinal microflora [19]. Mannan 
oligosaccharides (MOS) are nondigestible carbohydrates that are the main component in 
the outer cell wall of yeast cells (Saccharomyces spp.). While similar to prebiotics, MOS 
is not thought to selectively enrich intestinal bacteria, instead they are thought to bind to 
pathogenic bacteria and remove them from the intestinal tract [20]. Mannose is the main 
component of MOS and is a unique sugar. Many bacteria have mannose-sensitive 
receptors, called Type 1 fimbriae, which allow the bacteria to attach to the sugar rich 
epithelial lining of the intestinal tract. MOS can attach to this receptor and denying the 
bacteria from attaching to the intestinal tract. The MOS-bound bacteria can then be 
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Table 1. Ideal characteristics of probiotics and prebiotics1 
Probiotics 
   Be of host origin 
   Non-pathogenic 
   Withstand processing and storage 
   Resist gastric acid and bile 
   Adhere to epithelium or mucus 
   Persist in the intestinal tract 
   Produce inhibitory compounds 
   Modulate immune response 
   Alter microbial activities 
 
Prebiotics 
   Be neither hydrolyzed or absorbed by mammalian enzymes of tissues 
   Selectively enrich for one or a limited number of beneficial bacteria 
   Beneficially alter the intestinal microbiota and their activities 
   Beneficially alter luminal or systemic aspects of the host defense system 
1Adapted from Simmering and Blaut [21]; Patterson and Burkholder [2]. 
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flushed from the intestinal tract, decreasing the instance of pathogenic bacterial 
colonization [22]. This property makes MOS more of a CE product than a prebiotic. 
Organic acids are organic compounds that have acidic properties that can penetrate the 
bacterial cell wall and disrupt cell physiology [23]. Formic and propionic acids are 
examples that typically affect pH-sensitive bacteria, such as spp. of E. coli, Salmonella, 
Campylobacter, Listeria monocytogenes, and Clostridium perfringens. Bacteria that are 
pH-sensitive cannot deal with drastic changes in the pH gradient between intracellular 
and extracellular environments. Various plant extracts have shown to have antimicrobial 
abilities. Essential oils of various plants have shown the most potential for antimicrobial 
action. These products are typically used as a blend of different extracts, such as thyme, 
clove, black pepper, oregano, and yucca [22]. 
Objectives of the Study 
 The objectives of this body of research was to evaluate the impacts of removing 
in-feed, sub-therapeutic antibiotics, fed for growth promotion purposes, from the diets of 
commercial broiler chickens over a one year production period. Further studies were 
conducted to examine the potential for a probiotic (B. subtilis spores), competitive 
exclusion product (mannan oligosaccharide), and plant extract blend (plant extracts + 
mannan oligosaccharide + organic minerals) as potential alternatives to AGP, while 
determining their effects on broiler performance parameters. 
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CHAPTER II 
REVIEW OF LITERATURE 
Consequences of AGP Removal 
 The main expected consequence from the ban of AGP in the EU was a reduction 
in the use of antibiotics in animal production, eliminating the risk of transferring 
microbes with resistant genes to humans [5]. There has been conflicting data about the 
true consequences of removing antibiotics for growth promotion in the EU. One report 
explains that the broiler industry in Denmark has seen little affect from the banning of 
AGP from 1995 to 2002. Productivity and livability were not affected, but an increase in 
feed conversion has been seen over this time period. Mortality due to necrotic enteritis 
did not increase after the ban of AGP in Denmark. However, the use of the ionophore 
(ION), salinomycin, which has activity against Clostridium perfringens did increase 
steadily after the AGP ban. This may reflect the attempt of producers to control necrotic 
enteritis with the use of salinomycin [7]. On the other hand, some reports suggest that 
although the removal of AGP resulted in lower overall use of antimicrobials, the result 
has been an increase in the use of therapeutic antibiotics to combat infections [11, 24].  
In the US, a report by Chapman and Johnson [25] indicates that in 1995 an ANT 
was used in the starter, grower, and withdrawal diets by 94.3, 98.2, and 75.1% of broiler 
production units, but by 2000, there use had declined to 64.8, 66.9, and 48.1%, 
respectively. It was determined that between the years of 1995 and 2000, BMD was 
most frequently used in the starter and grower diets, whereas, VIR was most frequently 
found in the withdrawal diet. Broiler production units decreased their use of an ION + 
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ROX + antibiotic (ANT) combination from 1995 to 2000. This decline was likely due to 
the fact that ANT has a higher added cost to the feed as compared to ION and ROX, and 
coupled with producers belief that the growth-promoting effects once observed from 
these drugs was no longer evident. Furthermore, this data reflects the intense use of the 
same ANT by a majority of the broiler producers in the United States over an extended 
period of time, greatly increasing the chance of ANT-resistant populations.  
 In 2002, Engster et al. [26] conducted a comprehensive study to examine the 
effects of withdrawing AGP from the diets of commercial broiler chickens reared on the 
same farms, in two different geographic locations (Delmarva Peninsula and North 
Carolina), over a 3 year period of time. The control treatment received commercial diets 
containing a coccidiostat, ROX, and AGP program that was currently being used by the 
broiler integrator, and was compared to the trial treatment which received the same diets 
with no AGP. Results of the study showed that the removal of the AGP program reduced 
the average livability of the broilers by 0.2% on the Delmarva Peninsula and 0.14% in 
North Carolina. Furthermore, average body weight was decreased on the Delmarva 
Peninsula and in North Carolina by 0.03 and 0.04 lb, respectively. Feed conversion ratio 
increased in both locations by 0.016 and 0.012, respectively. This study indicates that 
removing the AGP program from the diets of broilers can have a negative impact on 
performance, but the information is dependent upon the length of the study and 
geographic locations evaluated. Further data is need to determine if the length of time 
can be adjusted to decrease the negative impacts seen, as well as, to determine if the 
geographic location and type of drugs has an effect on overall performance.     
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Probiotics 
 Fritts and colleagues [27] studied the effects of Bacillus subtilis spores C-3102 
(Calsporin), at an inclusion rate of 30 g/ton of completed feed, on broiler performance 
and carcass microbiological contamination in two trials. At 42 d, the combined results 
showed Calsporin significantly increase body weight and improved feed conversion at 
21 and 42 d. Aerobic plate counts, coliforms (non E. coli) and Campylobacter were 
significantly reduced in both studies on carcasses fed Calsporin when compared to those 
fed the control diet.  In 2004, four trials were conducted to evaluate the effects of 
Calsporin (Bacillus subtilis) spores, used as a direct-fed microbial probiotic, for 
improving broiler performance as an alternative to AGP [28]. Broiler chicks were reared 
for an average of 41 d for trials 1-3 and 49 d for trial 4. Trial diets included a basal diet 
with 0.05% Calsporin (contributing 0.003% as spores) with no AGP, while the control 
diets included the same basal diets with no Calsporin and no AGP for all trials. Hooge et 
al. [28] showed that Calsporin significantly increased body weight in all experiments 
with an average of 2.90% (+0.113 lb) increase, while decreasing feed conversion in 2 of 
the first 3 trials (average -1.46%). For trial 4, two additional treatments were added to 
the pervious treatments, which included the basal diet plus BMD at 55 ppm, and basal 
diet with Calsporin plus BMD. Results showed that the Calsporin diets produces higher 
body weights and lower feed conversion than the control diets, but not significantly 
better that the BMD and Calsporin/BMD supplemented diets. 
 Further research has demonstrated that probiotic species need not be active to be 
beneficial to the host. Canadian researchers tested two strains of disrupted, cobalt-
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enriched, lactic acid bacteria (Lactobacillus acidophilus and Lactobacillus casei) and a 
disrupted fungal mycelium (Scytalidium acidphilum) as in-feed probiotic additives at 
two levels, on broiler performance and immune response [29]. Low level L. casei, high 
level L. acidophilus, and high level fungal mycelium showed improved performance 
over the negative control treatment, but did not enhance the immune response in the 
birds. However, high level L. casei and low level L. acidophilus significantly stimulated 
a higher immune response of IgA compared to the negative control, 10 d post-
immunization. Similar research demonstrates that the 10 “generally recognized as safe” 
(GRAS) probiotic isolates used in poultry production are capable of increasing 
heterophil activity (oxidative burst and degranulation) in vitro [30]. Bacillus subtilis, 
Lactococcus lactis lactis, and Lactobacillus acidophilus isolates stimulated the greatest 
heterophil activity in vitro. These probiotic isolates were fed to broiler chicks and 
heterophil response was evaluated 24 h post-treatment. All three isolates showed a 
significant increase in oxidative burst and degranulation as compared to chicks receiving 
no probiotic isolate. The innate immune system (i.e., heterophils) responds much quicker 
to pathogens compared to the humoral immune system, indicating that probiotics can 
provide protection to newly-hatched chicks sooner.    
Prebiotics 
Studies that have examined the effects of prebiotics have shown conflicting 
results making it difficult to assess these additives. Fructooligosaccharide (FOS) has 
been the dominant prebiotic studied for poultry production. FOS fed to broiler chickens 
at a concentration of 0.375% yielded consistent improvement in growth rate and feed 
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efficiency [31]. However, FOS did not significantly reduce Salmonella contamination 
when the birds were processed. Fukata et al. [32], demonstrated the reduction of 
Salmonella enteritidis by feeding FOS. Two trials were conducted in which broiler 
chicks were fed diets containing 0.1% FOS and were challenged with S. enteritidis at 7 
d. No significant reduction of Salmonella was seen in the first trial.  In the second trial, 
the FOS treatment showed a significant reduction of S. enteritidis in the ceca when 
compared to the control, unchallenged birds at 1 and 7 d postchallenge. By 14 d, no 
significant reduction was seen among the FOS treatment in both studies. In a similar 
study, the effect of FOS fed at different levels on Salmonella colonization was examined 
[33]. FOS fed at a level of 0.375% had little effect on colonization, although 0.75% FOS 
reduced the colonization of Salmonella by 12% compared to the control group. Lactose 
cannot be enzymatically digested by the chicken, therefore making it a prebiotic 
ingredient. Chickens fed diets containing lactose exhibited reduced colonization of 
Salmonella typhimurium in the ceca [34]. Fernandez et al. [35] concluded that reduction 
of Salmonella colonization by feeding prebiotics, increases the prevalence of intestinal 
bacteria spp. of Bifidobacterium and Lactobacillus.   
Competitive Exclusion Concept 
 Several factors can reduce the efficacy of conventional CE products in chickens, 
such as the use of antibiotics, stress factors, disease, feed withdrawal, and contamination 
from the hatchery [36]. Zhang et al. [37] conducted studies to select isolates that could 
reduce Salmonella in chickens. Isolates were taken from 9 adult Salmonella and 
Campulobacter jejuni negative chickens. To ensure the isolates resistance to 
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Salmonella/C. jejuni plating assays were conducted using 6 strain of Salmonella and C. 
jejuni. Isolates that showed inhibitory zones were typed as Lactobacillus salivarius (6 
strains), Streptococcus cristatus, and Streptococcus mitis (2 strains). These isolates were 
then tested in vivo by feeding them to broiler chicks on d of hatch and the following d. 
On d 3, the birds were challenged with nalidixic acid-resistant Salmonella. At d 10, 
Streptococcus isolates were reduced S. typhimurium by 16%, while the L. salivarius 
isolates decreased S. typhimurium by 21% compared to the control group. 
Mannan oligosaccharides fit the definitions of both prebiotics and the CE 
concept. Due to its inability to selectively enrich intestinal bacteria and its potential to 
bind to bacterial receptors, MOS better fits into the category of CE. Spring et al. [20] 
tested the ability of different enteric pathogens and coliforms to trigger agglutination of 
yeast cells and MOS preparations. They determined that 5 species of E. coli and 7 
species of Salmonella agglutinated to yeast cells and MOS products. Broiler chicks were 
challenged at 3 d with Salmonella typhimurium 29E and fed a diet supplemented with 
4,000 ppm of MOS (Bio-MOS®) or an unsupplemented control diet in three trials. 
Results of all three trials showed a significant reduction in cecal S. typhimurium 29E at 
10 d. A second series of three consecutive trials were conducted using S. dublin as the 
challenge organism and again MOS diets significantly reduced the cecal concentations 
of S. dublin at 10 d. Finally, a trial was conducted with S. typhimurium 27A, which does 
not express type-1 fimbriae, to evaluate the effects of MOS on cecal concentrations. 
Cecal concentrations were not significantly lowered for S. typhimurium 27A, but were 
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numerically lower. Further research has shown that when MOS is used in combination 
with antibiotics a synergistic effect is seen to improve broiler performance [38, 39].   
Organic Acids 
 The antimicrobial mechanisms of organic acids are not fully understood, but they 
are capable of exhibiting bacteriostatic and bacteriocidial properties depending on the 
physiology of the organism and the physiochemical characteristics of the external 
environment [40]. Feeding different levels of a combination of formic and propionic 
acids (0.5 to 0.68%), reduced the incidence of Salmonella colonization compared to the 
untreated control treatment [41]. Cox et al. [42] tested the effects of butyric and lactic 
acids at a level of 0.5%, in diets fed to two groups of newly hatched chicks. On d 2, the 
two groups fed organic acids were challenged with S. typhimurium. Ceca were collected 
from 6 chicks at 7, 14, and 21 d to determine the prevalence of S. typhimurium. No 
significant reduction was experienced at d 7, but lactic acid reduced the colonization by 
1.6 logs. By d 21, both acids had significantly reduced intestinal colonization.  
Plant Extracts 
 The antimicrobial properties of various plant extracts have been tested in recent 
years. The essential oils (EO) of certain plant varieties have been shown to have 
antimicrobial effects in many in vitro studies. Studies using EO of thyme, clove, 
oregano, black pepper, and cinnamon have shown to have inhibitory effects on bacteria 
species in vitro; including S. typhimurium, E. coli, S. pullorum, and Clostridium 
sporogenes [43, 44, 45, 46, 47]. Mitsch et al. [48] tested the effects of two different 
blends of EO on Clostridium perfringens in broiler chickens. The two blends contained 
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different concentrations of EO from thyme (thymol) and oregano (carvacrol), with 
consistent levels of clove (eugenol), turmeric (curcumin), black pepper (piperin), and 
were fed at 100 ppm throughout the study. The first blend reduced the prevalence of C. 
prefringens in the feces at d 14, 21, and 30; in the jejunum and cecum on d 14 and 21; 
and in the cloaca on d 14. The second blend reduced C. perfringens in the jejunum on d 
14 and 30 and in the cloaca on d 30. Compounds found in plant extracts have been 
shown to have anticoccidial properties as well.  Yucca schidigera extract was shown to 
have a synergistic effect when supplemented through the diet of broilers vaccinated 
against coccidiosis [49]. Improvements to average daily gain and feed conversion were 
significant at d 42 and the intestinal villus length was higher at 6 d. Studies testing a 
blend of oregano and yucca extracts, along with organic minerals, improved average 
body weights, feed conversion and mortality (%) of broilers challenged with H. 
meleagridis [50]. Another study using the same blend supplemented in turkey diets, 
showed a reduction in the severity of intestinal lesions caused by dual infection of 
Cochlosoma anatis and coccidiosis (Eimeria spp.) compared to nonsupplemented, 
challenged birds [51].          
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CHAPTER III 
PERFORMANCE COMPARISON BETWEEN THE USE AND NON-USE OF AN 
ENTERIC HEALTH MEDICATION PROGRAM OVER FIVE CONSECUTIVE 
COMMERCIAL BROILER FLOCKS 
Introduction 
Over the past 60 years, antibiotics and anticoccidial drugs have been used to 
improve performance in agricultural animal production by reducing the burden of 
pathogens in the gastrointestinal tract [7, 25, 52]. The polyether ionophorous 
coccidiostats have been used extensively in broiler production for the control of 
coccidiosis [53]. Monensin (MON) and Salinomycin (SAL) were approved for use in 
broiler feeds by the FDA in 1971 and 1983, respectively, and since have become two 
drugs of choice for the prevention of coccidiosis to date [54]. These drugs achieve 
control by altering the permeability of protozoan cell membranes for alkaline metal 
cations thereby upsetting osmotic balance [55]. Antibiotics can be used therapeutically 
for treatment of poultry diseases, but are more commonly used in a prophylactic manner. 
Bacitracin Methylene Disalicylate (BMD) and Virginiamycin (VIR) have been included 
in poultry diets at sub-therapeutic levels since their approval for increased rate of gain 
and improved feed efficiency [54]. These antibiotics may also prevent the occurrence of 
the bacterial infection, necrotic enteritis, caused by Clostridium spp [56]. Roxarsone 
(ROX), another feed additive commonly used in broiler diets is an arsenical drug used 
for improving weight gain, feed efficiency and skin pigmentation [54]. ROX is also 
approved to aid anticoccidials in the control of Eimeria tenella oocysts [57]. Further 
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field experience has demonstrated the ROX may be effective at suppressing Salmonella 
and possibly other enteric organisms that can lead to food safety hazards in meat 
products [58].        
 While antibiotics and anticoccidials are effective in their own respect, overall 
intestinal health shows greatest improvement when these products are used in 
combination in broiler diets. The combination of an ionophore, roxarsone and an 
antibiotic in the starter and grower diets and an antibiotic alone in the withdrawal diet 
has become the industry standard [52]. While MON and SAL are only approved for 
control of coccidiosis, field experience has revealed that these drugs have an effect on 
controlling gram positive bacteria, combining them with an antibiotic and ROX takes 
advantage of synergism between the drugs [59].  
 Consumer pressure has forced the poultry industry worldwide to examine 
pathogen resistance from using feed additives on a continuous basis for prophylactic 
prevention of disease and improved performance [11,55]. Concerns arise from 
antimicrobial resistance to antibiotics used in animal feeds possibly resulting in 
microbial resistance in human medicine. This has lead to the ban of antibiotic growth 
promoters by the European Union in 2006, and the continuous decrease of using 
antibiotics at sub-therapeutic levels in the United States [7]. The objective of this study 
was to evaluate the effects on performance and yield by withdrawing antibiotic growth 
promoters from rations fed to commercial broiler over five consecutive flocks. 
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Materials and Methods 
Animals and Housing 
 This study was conducted in four solid-wall, tunnel ventilated commercial broiler 
houses, with dimensions of 43 ft wide and 500 ft long located on the Stephen F. Austin 
State University Broiler Research Center. Each house was identical in feeding, water and 
ventilation equipment. The four houses were divided into two paired-house facilities; 
with each paired-house facility received one of two treatments (treated or control) 
consistently throughout the five consecutive flocks. For each flock, 27,600 straight-run 
broiler chicks were placed in each house at a stocking density of 0.78 ft2 per bird. 
Multiple breeds of birds were placed throughout the trial with the majority being Ross 
708. At the hatchery, an equal number of chicks from the respective breeder flocks were 
randomly divided prior to placement in the paired-house facilities. Birds were reared to 
an average of 49 d under standard commercial industry practices. The same 
environmental and lighting regimes were used consistently from flock to flock. Birds 
received light for 23 hr at an intensity of 3.0 fc for seven days. From d 8 to 21, the 
photoperiod was reduced to 12 hr/day and the intensity was lowered to 0.10 fc.  The 
photoperiod was increased 2 hr each week for the remainder of the flock while the light 
intensity remained the same. Birds were placed on built-up litter from five previous 
flocks and no clean pine shavings were added between flocks. 
Feeding and Dietary Treatments 
 Birds were fed standard commercial corn-soy based diets formulated to meet the 
requirements of broilers chickens. Feeding phases consisted of a starter, grower, 
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withdrawal I (WDI) and withdrawal 2 (WDII) diets with feed changes approximately 
occurring at 18 d, 35 d, and 42 d, respectively. Feed and water was provided ad libitum 
via an automated feeding system and nipple drinkers. The treated group was fed a basal 
diet that included SAL (60.0 g/ton starter and grower), ROX (45.4 g/ton starter and 34.0 
g/ton grower), BMD (50.0 g/ton starter and 25.0 g/ton grower), and VIR (10.0 g/ton 
WDI); while the control group was fed the same diets containing SAL (60.0 g/ton starter 
and grower) but without ROX, BMD and/or VIR. Each flock received the same 
treatment over the course of the study. Samples were taken from each batch of feed and 
analyzed to ensure diets contained proper levels of coccidiostat, ROX, antibiotics and/or 
the absence of ROX and antibiotics.       
Yield Study and Data 
 A yield study was conducted at the completion of each flock using a total of 280 
birds from the four houses. At 48 d of age, 70 birds per house (35 males and 35 females) 
were randomly selected from each house. Each house was divided into five, 100 ft 
sections where 14 birds (7 males and 7 females) were selected to ensure a uniform 
representation of the house. A numbered wing-tag was placed in the wing of each bird 
and the birds were individually weighed and recorded. The birds were then removed 
from the house and placed in an isolation pen where feed was removed 12 hr prior to 
processing. Water was not removed from the birds until immediately prior to processing. 
Each yield study was conducted at approximately 49 d of age. At the Stephen F. Austin 
State University Pilot Processing Facility, the birds were stunned then bled using a knife 
to sever the jugular vein, scalded, defeathered, and manually eviscerated. The head, 
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neck, and paws were removed and discarded. Carcasses were then cut into front and hind 
halves and were weighed along with the abdominal fat. The front halves were skinned, 
wings were removed, breast filet and tenders (pectoralis major and pectoralis minor 
muscles) were deboned, leaving the frame (spine and rib cage). The hind halves were 
dissected to remove the drums and thighs, leaving the back. All parts were weighed 
individually and yields were calculated relative to final live bodyweight. Total white 
meat (breast filet + tenders) and percent total white meat ((total white meat / live 
bodyweight) * 100) were later calculated. 
The remaining broilers in the houses were taken to a processing plant and 
slaughtered under a commercial setting. Each paired house treatment group was 
removed, processed and tracked through the plant separately.    
Data Collected 
 For each flock of the trial, 200 randomly-selected birds (100 males and 100 
females) were individually weighed for each treatment group on d 18, 35 and 48. Birds 
were selected equally (10 males and 10 females) from five, 100 ft sections within each 
house to ensure uniform distribution. Using the commercial processing data of the 
remaining chickens, average body weights, feed conversion, adjusted feed conversion, 
livability and condemnation were calculated for each paired house treatment group. 
Coccidiosis lesion scores [60] of the duodenum, ileum and ceca were recorded from 5 
randomly-selected birds per house at 14, 21, 28, 35 and 42 d of age. Performance and 
yield data were analyzed by using the general linear models procedure of SAS software 
 23 
[61]. When significance between the treatments was observed (P < 0.05) means were 
separated using the least squares means test with the PDIFF option of this procedure.  
Results and Discussion 
Growth Performance 
 Table 2 shows the means of the treated and control groups for the 200 chickens 
that were weighed per treatment group at d 18, 35 and 48. At 18 d of age, the control 
group had an equal or higher average body weight for each of the five flocks, with the 
difference for flock 2 being significant. The overall five flock cumulative average 
between the treatments was 0.02 kg, with no significant difference. On d 35, the control 
group had a higher average body weight for each flock and a cumulative average 
differential of 0.02 kg, but the difference was not significant. At d 48, the control group 
had an equal or higher numerical average body weight for flocks 1, 2, and 3, but for 
flocks 4 and 5, the treated group had a numerically higher average body weight.  
 
TABLE 2. The effect of removing growth-promoting antibiotics (GPA) and roxarsone (ROX) on average 
bodyweight of broilers at 18, 35 and 48 d of age 
Average Bodyweight (kg) 2 
18 d 35 d 48 d 
Flock 1 Treated 3 Control 4 Treated Control Treated Control 
1 (06/08/06 – 07/27/06) 0.60 a 0.62 a 1.75 a 1.78 a 2.65 a 2.67 a 
2 (08/10/06 – 09/28/06) 0.48 b 0.50 a 1.74 a 1.76 a 2.74 a 2.74 a 
3 (10/12/06 – 11/30/06) 0.48 a 0.49 a 1.84 a 1.85 a 2.73 a 2.76 a 
4 (12/22/06 – 02/08/07) 0.53 a 0.56 a 1.80 a 1.83 a 2.78 a 2.76 a 
5 (03/06/07 – 04/24/07) 0.48 a 0.48 a 1.80 a 1.82 a 2.81 a 2.80 a 
Cumulative Average (1-5 flock) 0.51 a 0.53 a 1.79 a 1.81 a 2.74 a 2.74 a 
1Placement date of flock – ending date of flock. 
2Average bodyweight of 200 randomly-selected, individual bird weights per treatment group.  
3 Basal diets with coccidiostat, ROX and GPA. 
4 Basal diets with coccidiostat. 
a,b Means between treatment groups without a common superscript are significantly different (P < 0.05). 
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However, the 5 flock cumulative average body weight between the treatments at 48 d of 
age was equal and therefore no significance was detected. 
 Table 3 shows the impact of removing ROX and GPA from the diet of broilers 
processed in a commercial processing plant. The data reflects an average of 54,000 
broilers per treatment taken to market at approximately 49 d of age. The control group 
had a consistently higher numerical average body weight of 0.05 kg at the completion of 
flocks 1 and 2. By flock 3, the treated group had a 0.03 kg higher numerical average 
body weight as compared to the control group. The average body weight between the 
two groups was virtually equal for flocks 4 and 5. The cumulative average body weights 
for the five flocks show the control group had an overall 0.01 kg higher average than the 
treated group which was not significantly different. Most producers would expect the 
control group to have a higher average body weight for flocks 1 and 2 due to the absence 
of antibiotics coupled with a low microbial challenge in the house. By flock 3, with the 
absence of antibiotics they expect the microbial challenge to increase significantly and 
see the trend change to the advantage of the ROX and GPA treated group, this was not 
the case for this study. Engster et al. [26] demonstrated that average body weight was not 
adversely affected by removal of GPA for about one year.  
 Actual feed conversion seem to follow a similar trend as average body weight, 
with the control group having an equal or lower numerical feed to gain ratio than the 
treated group at 49 d of age for flocks 1, 4 and 5. The treated group had a lower 
numerical feed conversion for flock 2 and 3 with a difference from the control of 0.01 
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and 0.04, respectively. Cumulative feed conversion over the five flocks of the treated 
group was 0.01 lower than the control group, which was not statistically significant. 
  
TABLE 3. The effect of removing growth-promoting antibiotics (GPA) and roxarsone (ROX) on average 
bodyweight, feed conversion and adjusted feed conversion of broilers at 49 d of age 
Average Bodyweight 
(kg) 2 
Feed Conversion 
(g:g) 3 
Adjusted Feed 
Conversion (g:g) 4 
Flock 1 Treated 5 Control 6 Treated  Control  Treated  Control  
1 (06/08/06 – 07/27/06) 2.62 2.67 1.83 1.80 1.62 1.59 
2 (08/10/06 – 09/28/06) 2.60 2.65 1.81 1.82 1.61 1.61 
3 (10/12/06 – 11/30/06) 2.62 2.59 1.90 1.94 1.69 1.74 
4 (12/22/06 – 02/08/07) 2.60 2.60 1.92 1.92 1.71 1.72 
5 (03/06/07 – 04/24/07) 2.62 2.63 1.96 1.96 1.75 1.74 
Cumulative Average (1-5 flock)   2.61 a   2.62 a   1.88 a    1.89 a    1.68 a    1.68 a 
1Placement date of flock – ending date of flock. 
2Average bodyweight of remaining broilers processed under a commercial setting.  
3Feed Conversion = (lb feed/lb total bodyweight) 
4Adjusted to a 5 lb bird and 1500 calories with 7 weight/point of feed conversion. 
5 Basal diets with coccidiostat, ROX and GPA. 
6 Basal diets with coccidiostat. 
a Means between treatment groups without a common superscript are significantly different (P < 0.05). 
 
 
 
Feed conversion was adjusted for a 5 lb bird and a 1500 calorie (ME) diet with 7 
weight/point of feed conversion. The control group had a numerically equal or lower 
adjusted feed conversion for flocks 1, 2, and 5 with an average differential of 0.02 
points. Adjusted feed conversion was numerically lower for the treated group for flocks 
3 and 4 with an average differential of 0.03 points. When adjusted feed conversion was 
averaged over the five flocks both groups were equal and were not significantly 
different.  
 Table 4 shows the differences between the treatment groups for livability (%) 
and condemnation (%) of the paired-house groups at 49 d of age. Livability was shown 
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to be negatively affected over the five flock study by the omission of GPA and ROX 
from the diets. The treated group had a higher livability percentage for every flock and 
the cumulative average of 0.37% was statistically different, when compared to the 
control group. Condemnation at the processing plant varied from flock to flock between 
the treatments throughout the study. The treated group had a lower cumulative 
condemnation percentage at 49 days of age, but was not significantly different from the 
control group.     
 
TABLE 4. The effect of removing growth-promoting antibiotics (GPA) and roxarsone (ROX) on broiler 
livability (%) and condemnation (%) at 49 d of age 
Livability 2 
(%) 
Condemnation 3 
(%) 
Flock 1 Treated 4 Control 5 Treated Control 
1 (06/08/06 – 07/27/06) 98.29 97.73 0.45 0.86 
2 (08/10/06 – 09/28/06) 98.05 97.76 0.41 0.51 
3 (10/12/06 – 11/30/06) 98.28 97.82 0.54 0.45 
4 (12/22/06 – 02/08/07) 97.70 97.16 0.34 0.44 
5 (03/06/07 – 04/24/07) 97.98 97.95 0.41 0.33 
Cumulative Average (1-5 flock) 98.05 a 97.68 b 0.43 a 0.52 a 
1 Placement date of flock – ending date of flock. 
2 Livability (%) of remaining broilers processed under a commercial setting.  
3 Condemnation (%) of remaining broilers processed under a commercial setting.  
4 Basal diets with coccidiostat, ROX and GPA. 
5 Basal diets with coccidiostat. 
a,b Means between treatment groups without a common superscript are significantly different (P < 0.05). 
 
 
 
Coccidiosis Lesion Scores 
 Coccidiosis lesion scores were examined throughout the study to evaluate the 
effects of withdrawing ROX and GPA from the diets. Coccidial lesion scores between 
the treatment groups were significantly correlated with a value, r = 0.9141 (P = 0.0298), 
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from flock to flock. Lesion scores between the two treatment groups were not affected 
by the treatments as shown in Figure 1. 
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Figure 1. Correlation of coccidiosis lesion scores between treatment groups from 
flock to flock. (P < 0.05). Treated = basal diets with coccidiostat, roxarsone, and 
AGP; Control = basal diets with coccidiostat only. 
 
 
Yield Performance 
 Average live body weight of the birds selected and tagged for the yield study 
were not significantly different for any of the flocks or when accumulated for the entire 
study. The control group had numerically higher average eviscerated carcass weights for 
flocks 1-3, while the treated group weights were numerically higher for the last two 
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flocks. The control group had a 1,952 g average carcass weight compared to a 1,933 g 
average weight for the treated group over the course of the study, this difference was not 
significant. After the carcasses were divided into front and hind halves and the 
abdominal fat pad was removed, the control group had a numerically higher cumulative 
average for each respective product when compared to the treated group. 
 Table 5 shows the yield of the breast filet, tenders and wings after the front half 
was dissected into each of the respective cuts. Breast yield for the control group was 
numerically higher for flock 1-3, but was higher for the treated group for flocks 4 and 5. 
Cumulative numerical average breast yield for the control group was slightly higher than 
the treated group with a differential of 4.62 g. The numerical difference was not 
statistically significant; therefore the removal of ROX and GPA had no affect on breast 
yield. The control group had a numerically equal or higher tender yield over the course 
of the study with the exception of flock 4. At the completion of flock 2, the control 
group had an average tender yield of 108.86 g and was significantly different than the 
98.43 g average yield for the treated group. The control treatment had a 2.27 g greater 
cumulative average for tenders which were significant. Average wing yield was equal or 
higher for the control group for flocks 1-3, with a flock 2 average of 221.81 g being 
significantly different than the treated group average of 212.28 g. However, the 
cumulative average for the study was not statistically different between the two groups 
with an average of 213 g. 
 Table 6 shows the sum of breast filet and tender yield as total white meat 
production for each group. Again, the control group had a numerically higher total white 
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meat average for the first three flocks, while the treated group average was numerically 
higher for flock 4 and 5. By the end of the study, the control group had produced 7.35 g 
more total white meat than the treated group, which was not significantly different. 
 
TABLE 5. The effect of removing growth-promoting antibiotics (GPA) and roxarsone (ROX) on breast fillet, 
tender, and wing yield of broilers at 49 d of age 
Breast Fillet (g) Tenders (g) Wings (g) 
Flock 1 Treated 2 Control 3 Treated Control Treated Control 
1 (06/08/06 – 07/27/06)  391.45 a 404.60 a 94.80 a 96.62 a 205.48 a 206.38 a 
2 (08/10/06 – 09/28/06) 413.68 a 439.53 a 98.43 b 108.86 a 212.28 b 221.81 a 
3 (10/12/06 – 11/30/06) 410.50 a 412.32 a 99.34 a 102.51 a 211.83 a 211.83 a 
4 (12/22/06 – 02/08/07) 437.26 a 420.03 a 107.96 a 102.97 a 220.45 a 214.10 a 
5 (03/06/07 – 04/24/07) 435.45 a 435.00 a 106.14 a 106.14 a 215.46 a 210.47 a 
Cumulative Average (1-5 flock) 417.67 a 422.29 a 101.15 b 103.42 a 213.00 a 213.00 a 
1Placement date of flock – ending date of flock. 
2 Basal diets with coccidiostat, ROX and GPA. 
3 Basal diets with coccidiostat. 
a,b Means between treatment groups without a common superscript are significantly different (P < 0.05). 
 
TABLE 6. The effect of removing growth-promoting antibiotics (GPA) and roxarsone (ROX) on total 
white meat and percentage total white meat yield of broilers at 49 d of age 
Total White Meat 2 
(g) 
Percentage Total White Meat 3 
(%) 
Flock 1 Treated 4 Control 5 Treated Control 
1 (06/08/06 – 07/27/06) 485.80 a 501.67 a 18.59 a 19.23 a 
2 (08/10/06 – 09/28/06) 511.65 a 549.30 a 19.17 b 19.85 a 
3 (10/12/06 – 11/30/06) 509.84 a 515.28 a 18.85 a 18.88 a 
4 (12/22/06 – 02/08/07) 545.22 a 523.45 a 19.62 a 19.02 a 
5 (03/06/07 – 04/24/07) 541.14 a 540.68 a 19.35 a 19.56 a 
Cumulative Average (1-5 flock) 518.73 a 526.08 a 19.12 a 19.31 a 
1 Placement date of flock – ending date of flock. 
2 Total White Meat = (breast filet + tenders)  
3 Percentage Total White Meat = (total white meat / live body weight)*100  
4 Basal diets with coccidiostat, ROX and GPA. 
5 Basal diets with coccidiostat. 
a,b Means between treatment groups without a common superscript are significantly different (P < 0.05). 
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Table 6 shows the percentage of total white meat produced related to live body 
weight by group. Percentage of total white meat was numerically higher for the control 
group for the majority of the study, with the exception of flock 4. The control group 
(19.85 %) had a significantly higher percentage of total white meat for flock 2, as 
compared to the treated group (19.17 %). The cumulative average over all flocks shows 
that the removal of ROX and GPA from the diet had no adverse affect on the percentage 
of total white meat produced. 
 The hind half was dissected to evaluate the drums, thighs and back yield of the 
carcass. Drum yield was significantly higher for the control group for the first flock of 
the study and remained numerically higher for flocks 2-3. The treated group had a 
numerically higher drum yield for flock 4, while the groups flock 5 averages were equal. 
Both treatments had an equal cumulative average yield for drums of 270.34 g. The 
control group had a numerically higher thigh yield for flocks 1 & 2, while the treated 
group had heavier thigh yields for flocks 3-5. The treated group had a 1.36 g numerically 
higher cumulative average over the control group which was not significant. Back yield 
was numerically higher for the control group for flocks 1-3 while the treated group had 
numerically higher yields for flocks 4 & 5. The control group had a numerically higher 
cumulative average back yield of 4.99 g as compared to the treated group, which was not 
significantly different. 
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CHAPTER IV 
EFFICACY OF BACILLUS SUBTILIS SPORES (Gallipro®) ON 
PERFORMANCE OF COMMERCIAL BROILER CHICKENS 
Introduction 
Enteric diseases are economically important to the poultry industry due to lost 
productivity, increased mortality, cost of prevention measures, and the associated 
contamination of poultry products for human consumption. Changes in the poultry 
industry, such as an increase in antibiotic resistance, banning sub-therapeutic antibiotic 
usage in the European Union, declining usage with potential banning of these drugs in 
the United States, and an overwhelming consumer demand for the removal of these 
drugs, has lead to an increase in finding alternatives to antibiotics for poultry production 
[2]. Organic poultry production is a sector of the industry that has gained popularity with 
consumers. Consumers are willing to pay a premium for organic poultry products that 
meet governmental regulations prohibiting the use of antibiotics for any reason [22]. 
Many potential alternatives to antibiotics have been tested, both in vivo and in vitro, for 
their ability to improve bird performance and reduce the spread of disease.  
Probiotics is one alternative ingredient that has shown potential to improve 
performance that is comparable to antibiotics. Probiotics are defined as a live microbial 
feed supplement which beneficially affects the host animal by improving its intestinal 
balance [17]. Probiotics can be comprised of a single or multiple bacterial species, 
generally containing species of Bacillus, Bifidobacterium, Enterococcus, E. coli, 
Lactobacillus, Lactococcus, Streptococcus, and a variety of yeast species [2]. Probiotics 
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should have certain characteristics to be beneficial as a direct-fed microbial. For 
instance, the probiotic should not be hydrolyzed nor absorbed by enzymes or tissues of 
the host. Probiotics should have the ability to selectively enrich for one or a limited 
number of intestinal bacteria that are beneficial to the host. Furthermore, probiotics 
should be able to beneficially alter the activities of the intestinal microbiota. Finally, 
probiotics should beneficially stimulate the host’s immune system [21].  
 A number of Bacillus spp. have been considered safe for use in poultry 
production. Bacillus spp. can exist as vegetative cells or when placed in a stressful state 
produce spores that are heat resistant and tolerant to bile salts [62]. These characteristics 
are advantageous for poultry production, allowing the spores to be included in the feed 
while withstanding the high temperatures of the pelletizing process and survive the 
effects of bile salts in the intestinal tract. Bacillus subtilis spores have been shown to 
withstand heat up to 100oC for several minutes and continue to germinate into vegetative 
cells after exposure to 0.5% bile salts [63]. Strains of B. subtilis have been shown to 
exclude pathogenic bacteria, including spp. of E. coli, Salmonella, Clostridium, 
Streptococcus and Campylobacter, from colonizing in the gastrointestinal tract of 
poultry [62, 64, 65, 66]. Both the humoral and innate immune systems can be potentiated 
by B. subtilis spp. in the gastrointestinal tract of chickens [30, 67, 68, 69]. Improvements 
in performance parameters, including weight gain and feed efficiency, have been 
reported when using various B. subtilis strains as probiotics in poultry [27, 28, 70, 71]. 
The objective of this study was to evaluate the effects of in-feed, B. subtilis spores 
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(Gallipro®, Chr Hansen A/S, Denmark) on the performance of commercial broiler 
chickens. 
Materials and Methods 
Animals and Housing 
This experiment was conducted at the Stephen F. Austin State University Broiler 
Research Center in four solid-wall, tunnel ventilated commercial broiler houses, with 
dimensions of 43 ft wide and 500 ft long. Each house was identical in feeding, water and 
ventilation equipment. The four houses were divided into two paired-house facilities; 
with each paired-house facility receiving diets either supplemented with in-feed, B. 
subtilis spores (Gallipro®, Chr Hansen A/S, Denmark) or diets containing a standard 
AGP program. Each broiler house was filled with 27,600 Ross 708, straight-run broiler 
chicks, with a total placement of 55, 200 broilers per treatment. Birds were placed at a 
stocking density of 0.78 ft2 per bird. In order to ensure uniformity between the treatment 
groups, chicks from different breeder flocks were equally distributed between the two 
groups at the hatchery prior to arrival at the farm. Under standard commercial industry 
practices the birds were reared for 48 d. The environmental and lighting regimes were 
consistent from house to house. Birds received light for 23 hr at an intensity of 3.0 fc for 
seven days. The length and intensity of light was reduced at d 8 to 12 hr/day and 0.10 
fc., respectively.  The length of lighting was increased 2 hr each week for the remainder 
of the flock while the light intensity remained the same. Birds will be placed on built-up 
litter from eight previous flocks and no clean pine shavings will be added prior to the 
placement of birds. 
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Feeding and Dietary Treatments 
 All diets were commercially made with a corn-soy base and formulated to meet 
the NRC requirements for broilers chickens. Feeding phases consisting of a starter, 
grower, withdrawal I (WDI) and withdrawal 2 (WDII) diets were fed with feed changes 
approximately occurring at 18 d, 35 d, and 42 d, respectively. The treatment group 
received basal diets at each phase that was supplemented with B. subtilis spores (0.25 
lb/ton starter – WDII), and were compared to a control group receiving the same basal 
diets containing Flavomycin (2.0g/ton starter and grower). Both treatment groups 
received a coccidiostat program comprised of Salinomycin (60.0 g/ton starter), 
Monensin (100 g/ton grower) and Narasin (72 g/ton WDI); and the growth enhancer, 
Roxarsone (ROX) (45.4 g/ton starter and 22.7 g/ton grower). Samples were taken from 
each batch of feed and analyzed to ensure diets contain proper levels of coccidiostat, 
ROX, antibiotics and B. subtilis spores. Feed and water were provided ad libitum via an 
automated feeding system and a nipple drinker system.       
Floor Pen Data 
 Prior to the placement of birds, a total of 8 floor pens, each measuring 6 ft X 6 ft, 
were evenly divided between the two paired-house facilities. Four replicate floor pens 
were equally spaced on the brood end of one house per treatment group. In each pen, 50 
randomly-selected chicks were placed at a stocking density of 0.72 ft2 per bird, and 
reared to 48 d of age. Each pen was fed ad libitum via one hanging tube feeder and 
received water ad libitum via a nipple drinker system. All feed was weighed and 
recorded prior to placement into the pen.  
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Data Collected 
 Throughout the experiment each floor pen was collectively weighed for each 
treatment group on d 18, 35 and 48. Average body weight and feed conversion ratio was 
calculated for each floor pen and treatment group at d 18, 35 and 48. At 48 d of age, all 
birds were removed from the houses and transported to a local commercial processing 
facility to be slaughtered. All birds for each paired-house facility was removed 
separately and followed through the processing facility, in order to calculate average 
body weights, feed conversion, adjusted feed conversion, percent mortality, and percent 
condemnation. On d 14, 21, 28, 35, and 42, five randomly-selected birds were selected 
from each house, humanely euthanized, and necropised. Coccidiosis lesion scores [60] 
of the duodenum, ileum and ceca were examined and recorded. The bird’s footpads were 
scored on a 0 to 3 scale (0 = normal; 1 = slight degradation; 2 = moderate degradation; 3 
= severe degradation). Performance data was analyzed by using the general linear 
models procedure of SAS software [61]. Means were separated using the Duncan’s 
Multiple Range Test, if differences between the treatments were significant (P < 0.05). 
Results and Discussion 
Floor Pen Data 
 The floor pen data for average body weights at d 18, 35 and 48 are shown in 
Figure 2.  The treatment group had a numerically higher average body weight as 
compared to the control group at 18 and 48 d, with a differential of 0.06 and 0.03 kg, 
respectively. At 35 d of age, the control group had higher numerical average body 
weight than the treatment group with a differential of 0.02 kg. No significant differences  
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Figure 2. Treatment effect on average body weight of floor pen birds for growth 
days 18, 35 and 48 (P < 0.05). B. subtilis = Bacillus subtilis spores (0.25 lb/ton starter 
– WDII); AGP = Flavomycin (2.0g/ton starter and grower). Four replicate pens per 
treatment containing 50 birds/pen. 
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Figure 3. Treatment effect on feed conversion of floor pen birds for growth days 18, 
35 and 48 (P < 0.05). B. subtilis = Bacillus subtilis spores (0.25 lb/ton starter – 
WDII); AGP = Flavomycin (2.0g/ton starter and grower). Four replicate pens per 
treatment containing 50 birds/pen. 
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were observed for average body weights between the treatment groups at d 18, 35 and 
48. The effect of the treatments on feed conversion ratio for the birds reared in the floor 
pens are shown in Figure 3. Feed conversion ratio was calculated for the 50 birds/pen at 
18, 35 and 48 d of age. There was a significant difference between the treatment and 
control groups at d 18 and 48. At d 18, the treatment group had a 0.22 lower feed 
conversion than the control group, while at d 48 the difference was 0.04. The feed 
conversion ratio at d 35 was not significantly different between the groups. 
Commerical Paired-house Facility Data 
 Table 7 shows the effects of B. subtilis spores and an AGP program on the 
performance of 110,400 broiler chickens evenly distributed between two commercial 
paired-house facilities reared to 48 d of age. At 48 d of age, the control group fed diets 
containing Flavomycin had a higher numerical average body weight than the treatment 
group receiving diets containing B. subtilis spores. The treatment group was more feed 
efficient than the control group at 48 d with a 0.02 point lower feed conversion ratio. 
The feed conversion ratio was adjusted for a 5.0 lb average bird, fed a 1500 kcal average 
diet, with 7 weight points of feed conversion. After calculating the adjusted feed 
conversion ratio, the treatment group still had a numerically lower adjusted feed 
conversion ratio when compared to the control group, with a differential of 0.02 points. 
Mortality (%) was consistently lower in the control group when examined at d 7, 14, and 
48, with differentials of 0.11, 0.63, and 0.08 %, respectively. Condemnation (%) at the 
processing plant was numerically lower for the treatment group at 48 d of age. The 
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majority of the condemnation difference between the treatments was due to septicaemia 
and toxemia, and airsacculitis, which were both higher for the control group. 
 Coccidiosis lesion scores were taken at d 14, 21, 28, 35, and 42 to determine the 
effectiveness of the coccidiosis control program used and to evaluate any potential 
effects between the treatments. Coccidial lesions were similar between the treatment 
groups from week to week, with the amount and severity of lesions increasing gradually 
from d 28 to 42 for both groups. Lesion scores between the two treatment groups were 
not affected by the treatments (Data not shown). Footpads were scored at d 14, 21, 28, 
35, and 42 to examine any ulcerations or degradation of the skin tissue due to litter 
conditions. Litter conditions were consistent between the houses and were maintained at 
a relatively low moisture content, therefore all birds necropsied throughout the 
experiment did not exhibit any signs of ulcerations or degradation and were scored as 
normal (Data not shown). 
 
 
TABLE 7. The effect of B. subtilis spores and an antibiotic growth promoter program on performance 
parameters of commercial broiler chickens in paired-house facilities1 at 48 d of age 
Measurement Treatment Control 
Average Body Weight (kg) 2.42 2.44 
Feed Conversion Ratio2 1.85 1.87 
Adjusted Feed Conversion Ratio3 1.70 1.72 
Mortality (%)4   
     7 d 0.80 0.69 
   14 d 1.60 0.97 
   48 d 1.78 1.70 
Condemnation (%)5 0.30 0.34 
1 Paired-house facility contains 55,200 broiler chickens receiving one of two dietary treatments.  
2 Feed conversion ratio = g of feed / g of weight. 
3Adjusted feed conversion ratio = [(((feed conversion – (avg body weight – 5.0 lb))/ 7 weight points)* 1435                                  
kcal)/1500 kcal].  
4 Mortality (%) = [(total mortality/total bird placement)*100].  
5 Condemnation (%) = [(total gross live weight/total gross condemnation weight)*100]. 
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CHAPTER V 
EFFICACY STUDY OF SUPPLEMENTING Bio-Mos® AND Natustat™ FOR 
ANTIBIOTIC GROWTH PROMOTERS ON BROILER PERFORMANCE AND 
YIELD  
Introduction 
There have been global changes in the use of antibiotics for growth promotion in 
the poultry industry. Antibiotic growth-promoters (AGP) are fed to poultry to increase 
the rate of gain and improve feed efficiency 54]. Some AGP aid in the prevention of 
necrotic enteritis, such as bacitracin methylene disalicylate (BMD) and virginiamycin 
(VIR). Roxarsone (ROX) is an arsenical drug that is often used in combination with an 
AGP program to improve weight gain and feed efficiency. ROX may be used in 
conjunction with an ionophore coccidiostat (i.e., salinomycin (SAL)) to aid in the control 
of coccidiosis, caused by Eimeria tenella [72]. There are several concerns related to the 
use of AGP in poultry production have contributed to these changes. Development of 
resistance to antibiotics by pathogenic bacteria has been the major concern and was 
observed as early as the 1950’s, shortly after discovering the beneficial effects of AGP 
on production [7]. Antimicrobial resistance has increased over the years, potentially due 
to the intensive use of antibiotics at subtherapeutic levels to increase weight gain and 
improve feed efficiency [25]. Further concern is the human health risks related to 
antimicrobial resistance by mainly zoonotic bacteria that can be spread from infected 
animals to humans [11]. The potential for public health risks has lead poultry product 
consumers to place significant pressure on the poultry industry to change the practice of 
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feeding antibiotics for disease prevention. This increased pressure by the consumer has 
resulted in voluntary reduction of AGP use by some major poultry producers in the US 
and has forced restaurant chains to eliminate the use of products from chickens grown 
using AGP [16].  
The poultry industry has been forced to explore potential alternatives to AGP. 
Competitive exclusion (CE) cultures have been a potential alternative to AGP that has 
been tested and shown to improve the health and performance of chickens. Since, newly-
hatched chicks lack intestinal microflora, they are especially prone to enteric pathogens 
until the microbiota are established [73]. In 1971, a severe outbreak of Salmonella 
infantis occurred among broiler flocks in Finland. Antibiotic treatment was unsuccessful 
at relieving the problem, so E. Nurmi at the National Veterinary Institute, Helsinki, 
Finland, took a different approach by isolating cultures of cecal microflora from adult 
chickens and administered them to newly-hatched chicks [19]. This concept of taking 
adult cecal cultures that were resistant to Salmonella and establishing adult-type 
resistance in the young chicks in now referred to as the competitive exclusion or the 
Nurmi-concept. One mode of action for CE cultures is to compete with pathogens for 
attachment sites on the mucosal surface of the intestine, thereby excluding these 
pathogenic species [74].    
 Mannan-oligosaccharides (MOS, Bio-Mos®, Alltech, Nicholasville, Kentucky, 
USA) is a non-digestible, complex carbohydrate that is the main component in the outer 
cell wall of yeast cells (Saccharomyces cerevisiae var. boulardii), and is thought to act 
by binding and removing pathogens from the intestinal tract and stimulates the immune 
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system [2]. One potential mode of action for MOS is its ability to adsorb pathogenic 
bacteria that contain type-1 fimbriae with mannose-sensitive lectin proteins [75]. 
Another probable mode of action that has been reported for MOS is an improvement in 
the function of the intestinal tract by increasing villi height, uniformity and integrity 
[76]. MOS products are thought to stimulate gut associated and systemic immunity by 
acting as non-pathogenic microbial antigens [77]. MOS products are thought of as CE 
products because of these probable modes of action. 
 Many researchers have shown that MOS have a positive effect on BW and FCR, 
while either having no effect or lowering mortality in chickens and turkeys [28, 52, 78, 
79]. Research has shown that some strains of pathogenic bacteria can trigger 
agglutination of MOS and reduce the susceptibility of bacterial colonization in the 
intestinal tract [20, 35]. Further research has shown that when MOS is used in 
combination with antibiotics a synergistic effect is seen to improve broiler performance 
[38, 39].   
 Natustat™ (NAT, Alltech, Nicholasville, Kentucky, USA), is a proprietary plant 
derived product, used as an alternative for the control of histomoniasis, caused by 
Histomonas meleagridis, in poultry [50, 80], and dual infection of Cochlosoma anatis 
and coccidiosis (Eimeria spp.) in turkeys [51]. NAT is a natural product that is 
comprised of at least one yeast-derived mannan-oligosaccharide, along with organic 
mineral nutrients and plant extracts. This product has been shown to provide 
improvements to BW, FCR and mortality (%) of broilers challenged with H. meleagridis 
[50]. NAT supplemented diets reduces the severity of intestinal lesions caused by dual 
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infection of Cochlosoma anatis and coccidiosis (Eimeria spp.) in turkeys when 
compared to nonsupplemented, challenged birds [51]. The objective of this study was to 
evaluate the effectiveness of MOS as an alternative to a commercially standard AGP 
program or a combination of MOS/NAT as an enteric health replacement program. The 
effects of MOS and NAT on broiler performance and yield were observed.  
Materials and Methods 
Animals and Housing 
A total of 6,000, straight-run Cobb X Cobb broiler chickens were reared at the 
Stephen F. Austin State University Poultry Research Center. This floor-pen facility 
contains 48 pens, each measuring 10 ft. X 10 ft., in which 125 birds were randomly 
assigned to each pen at a stocking density of 0.80 ft2 per bird. The birds were reared for 
49 days to a target average weight of 6.00 lb. Environmental conditions were controlled 
by negative air exchange (tunnel ventilation) and emulated commercial settings. The 
floor-pens contained built-up litter comprised of wood shavings from six previous 
flocks.  
Feeding and Dietary Treatments 
 Corn-soy based basal diets were fed and formulated to meet or exceed the 
requirements of broilers chickens. Diets were prepared and pelletized at the Stephen F. 
Austin State University Poultry Research Feed Mill prior to bird placement. Feeding 
phases consisting of a starter, grower, finisher and withdrawal (WD) diets were fed with 
feed changes approximately occurring at 14 d, 28 d, and 40 d, respectively. The starter 
diet was fed as a crumble with the remaining diets feed as pellets. Feed and water were 
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provided ad libitum via 4 hanging tube feeders and 2, 10 ft. nipple drinker systems per 
pen. Each pen was randomly assigned 1 of 4 dietary treatments, with each treatment 
having 12 replications setup in a randomized block design. The treatments consisted of 
the following: control (CON), basal diets containing SAL (50.0 g/ton starter, 60 g/ton 
grower and finisher), and no AGP or CE products; antibiotic program (ANT), basal diets 
containing SAL (50.0 g/ton starter, 60 g/ton grower and finisher), BMD (50 g/ton starter, 
grower, and 25 g/ton finisher), ROX (45.4 g/ton grower and 39 g/ton finisher), and VIR 
(10 g/ton WD); Bio-Mos® replacement (MOS), basal diets containing SAL (50.0 g/ton 
starter, 60 g/ton grower and finisher), and Bio-Mos® (4 lb/ton starter, 2 lb/ton grower,1 
lb/ton finisher and WD); and Bio-Mos®+Natustat™ replacement (MOS+NAT), basal 
diets containing Natustat™ (2 lb/ton starter and grower), and Bio-Mos® (1 lb/ton finisher 
and WD). The MOS/NAT birds were vaccinated prior to placement in the pens with 
Coccivac®-B coccidiosis vaccine and were not fed a coccidiostat.  
Yield Study and Data  
 A yield study was conducted at the completion of the experiment using a total of 
384 birds. At 49 d of age, 8 birds per pen (4 males and 4 females) were randomly-
selected from each pen. Males and females were differentiated by visual appearance and 
sexual characteristics. Each treatment had 12 replications for a total of 96 birds per 
treatment. Each bird had a numbered wing-tag that was placed in one wing and the birds 
were individually weighed and recorded. The birds were removed from the pens and 
placed in an isolation pen with feed until 12 hr prior to processing. Water was provided 
for the birds until immediately prior to processing. At the Stephen F. Austin State 
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University Pilot Processing Facility, the birds were stunned and manually eviscerated. 
The head, neck, and paws were removed and discarded. Carcasses were then split into 
front and hind halves and weighed along with the abdominal fat. The front halves were 
skinned, then dissected to obtain the wings, deboned to obtain the breast fillet and 
tenders (pectoralis major and pectoralis minor muscles), leaving the frame (spine and rib 
cage). The hind halves were dissected to remove the drums and thighs, leaving the back. 
All parts were weighed individually and yield data was calculated relative to final live 
bodyweight. Total white meat (breast fillet + tenders) and percent total white meat ((total 
white meat / live bodyweight) * 100) will be calculated at a later period.  
Data Collected 
 All feed was weighed and recorded prior to placement in the pens. The birds in 
each pen were weighed collectively at d 49, along with the remaining feed. Daily 
mortalities were weighed, necropsied and probable cause of death was recorded. 
Average body weight, feed conversion ratio, mortality adjusted feed conversion ratio and 
percent mortality were calculated at 49 d of age. Performance and yield data were 
analyzed by using the general linear models procedure of SAS software [61]. If 
significance differenced between the treatments are observed (P < 0.05), means will be 
separated using the Duncan’s Multiple Range Test. 
Results and Discussion 
Performance Data 
The treatment effects on average body weight, feed conversion ratio, mortality-
adjusted feed conversion ratio, and percent mortality at 49 d of age is shown in Table 8. 
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Average body weight for the CON and ANT groups were significantly different than the 
MOS+NAT treatment on d 49 by a differential of 0.11 kg, but was not significantly 
different than the MOS group. No significant differences were detected between the 
treatments for feed conversion ratio, mortality-adjusted feed conversion ratio, and 
percent mortality at 49 d of age. The MOS+NAT treatment was vaccinate with a 
coccidiosis vaccine prior to placement, which could have had an effect on overall 
performance. 
 
 
TABLE 8. Effects of antibiotic growth-promoters, Bio-Mos, and Natustat on BW, FCR, mortality-adjusted 
FCR, and mortality of broilers at 49 d of age 
Treatment 1 BW (kg) FCR (kg:kg) Mortality-adjusted FCR (kg:kg) Mortality (%) 
CON 2.96 a 1.94 a 1.92 a 5.28 a 
ANT 2.96 a 1.94 a 1.92 a 4.41 a 
MOS  2.91 ab 1.95 a 1.93 a 4.09 a 
MOS+NAT 2.85 b 1.97 a 1.95 a 5.68 a 
1Treatment codes: CON = control; ANT = antibiotic growth-promoter; MOS = mannanoligosaccharide (Bio-Mos); 
MOS+NAT = Bio-Mos/Natustat (plant-derived blend) 
a,b Means between treatment groups without a common superscript are significantly different (P < 0.05). 
 
 
 
Yield Data 
 Yield data was collected and analyzed from 384 randomly-selected birds at 49 d 
of age. Table 9 shows the effects of the treatments on the parts that comprise the front 
half of the carcass. The front half consists of the wings, breast, tenders, frame, and skin. 
There were no significant differences between the treatments for wing, breast, and tender 
yield. All treatments were significantly different from the MOS+NAT group for frame 
weight, with the MOS group having the highest frame yield. ANT group had the highest 
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skin yield of the treatments and along with the CON and MOS groups was significantly 
different from the MOS+NAT treatment group at 49 d of age.  
 
 
 
 
 The d 49 yield data for the parts that comprise the hind half of the carcass are 
shown in Table 10. The drums, thighs, back, and abdominal fat comprise the hind half of 
the carcass. Differences between the treatments for drums, thighs, back, and abdominal 
fat at 49 d of age were not significant when compared.  
 
 
 
 
TABLE 9. Treatment effects of antibiotic growth-promoters, Bio-Mos, and Natustat on wing, breast, tender, 
frame, and skin yield of broilers at 49 d of age. 
Treatment1 Wing (g) Breast (g) Tender (g) Frame (g) Skin (g) 
CON  224.07 a 449.06 a 102.51 a 304.36 a 106.59 a 
ANT  230.88 a 450.42
 a
 105.69 a 303.91 a 111.13 a 
MOS  221.81 a 449.96
 a
 103.87 a 305.72 a 107.50 a 
MOS/NAT  223.62 a 440.44
 a
 104.78 a 287.12 b   99.34 b 
1Treatment codes: CON = control; ANT = antibiotic growth-promoter; MOS = mannanoligosaccharide (Bio-Mos); 
MOS+NAT = Bio-Mos/Natustat (plant-derived blend) 
a,b Means between treatment groups without a common superscript are significantly different (P < 0.05). 
TABLE 10. Treatment effects of antibiotic growth-promoters, Bio-Mos, and Natustat on drum, thigh, back, 
and abdominal fat yield of broilers at 49 d of age. 
Treatment1 Drum (g) Thigh (g) Back (g) Abdominal fat (g) 
CON 289.39 a 343.37 a 235.41 a 57.61 a 
ANT 291.66 a 350.63 a 237.68 a 60.33 a 
MOS 280.32 a 340.19 a 230.88 a 59.87 a 
MOS/NAT 283.95 a 335.66 a 227.25 a 54.43 a 
1Treatment codes: CON = control; ANT = antibiotic growth-promoter; MOS = mannanoligosaccharide (Bio-Mos); 
MOS+NAT = Bio-Mos/Natustat (plant-derived blend) 
a Means between treatment groups without a common superscript are significantly different (P < 0.05). 
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 Data in Table 11 demonstrates the effects of the treatments on the whole carcass 
weight, the collective means of the front and hind halves of the carcass, the total white 
meat yield and the percentage of total white meat produced. The ANT group, followed 
by the CON and MOS groups, significantly improved carcass front half yield when 
compared to the MOS+NAT group. Carcass hind half yield was significantly improved 
by for the CON group, along with the ANT and MOS groups over the MOS+NAT group 
at d 49. No significant differences were detected between the treatments for whole 
carcass weight and total white meat yield. Conversely, when the percent total white meat 
yield was calculated relative to the live weight of the bird, the MOS group had a 
significantly higher percentage of white meat as compared to the ANT group, but was 
not different from the MOS+NAT and CON treatment groups. 
 
 
TABLE 11. Treatment effects of antibiotic growth-promoters, Bio-Mos, and Natustat on carcass, front half, 
hind half, total white meat, and percent total white meat yield of broilers at 49 d of age 
Treatment1 
Carcass Weight 2 
(kg) 
Carcass Front Half 
3
 
(kg) 
Carcass Hind Half 4 
(kg) 
Total White 5 
Meat (kg) 
Percent Total 
White Meat 6 
(%) 
CON  2.11 a   1.20 ab 0.88 a 0.55 a   18.48 ab 
ANT 2.12 a 1.22 a  0.86 ab 0.57 a 18.14 b 
MOS 2.05 a   1.19 ab  0.85 ab 0.55 a 18.70 a 
MOS/NAT 2.00 a 1.15 b 0.82 b 0.55 a   18.51 ab 
1Treatment codes: CON = control; ANT = antibiotic growth-promoter; MOS = mannanoligosaccharide (Bio-Mos); 
MOS+NAT = Bio-Mos/Natustat (plant-derived blend) 
2 Carcass Weight = carcass wt. – (neck + head + paws + giblets) 
3 Carcass Front Half = wings + breast + tenders + frame + skin 
4 Carcass Hind Half = drums + thighs + back 
5 Total White Meat = Total White Meat = (breast + tenders)  
6 Percent Total White Meat = ((breast + tenders) / live body weight)*100  
a,b Means between treatment groups without a common superscript are significantly different (P < 0.05). 
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
The primary aim of this research was to determine the impact of AGP removal from 
the diets of commercial broiler chickens, over a one year production period. 
Furthermore, to determine the effectiveness of a probiotic (B. subtilis spores), 
competitive exclusion product (mannan oligosaccharide), and plant extract blend (plant 
extracts + mannan oligosaccharide + organic minerals) as alternatives to AGP. 
In the first study, the removal of ROX and AGP from the diets of commercial 
broilers over five consecutive flocks showed no negative effects on broiler performance. 
Feed conversion was not affected by the removal of ROX and AGP from the diets 
throughout the study. The cumulative average feed conversion and adjusted feed 
conversion were not significantly different at 49 d. Livability percentage was negatively 
affected by the removal of ROX and AGP over the five consecutive flocks. The removal 
of ROX and AGP had no affect on coccidiosis lesion scores throughout the course of the 
study. Overall carcass yield was not affected by the removal of these drugs from the 
diets. While the data from this study demonstrated that broilers reared without ROX and 
AGP in a commercial setting can perform as well as birds receiving prophylactic 
antimicrobial drugs, these results must be interpreted in context. Research has shown 
that broiler performance may not be negatively affected until after the first year without 
prophylactic drug use [26] and the conditions of the environment can have a large role in 
the success or failure of an enteric health medication program [81].   
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In study two, feed conversion ratio was improved by the inclusion of B. subtilis 
spores at d 18 and 48, while not affecting average body weight. The inclusion of B. 
subtilis spores had no affect on coccidiosis lesion scores and footpad condition. B. 
subtilis spores (Gallipro®), fed to commercial broiler chickens at an inclusion rate of 
0.25 lb/ton, proved to be beneficial as an alternative to antibiotic growth promoters.   
In study three, broilers reared to 49 d fed diets supplemented with MOS had average 
body weights, feed conversion ratio and mortality that was statistically equal to broilers 
fed diets that either did or did not contain AGP. All treatments had a significantly higher 
carcass front half, carcass hind half, frame and skin yield when compared to the 
MOS+NAT treatment. MOS supplemented diets significantly improved the percentage 
of total white meat yield relative to the live weight of the bird when compared to diets 
including AGP. MOS can be used as an alternative to AGP that provides equal 
performance and yield for broilers reared to 49 d under simulated commercial settings. 
The combination of MOS+NAT was not found to be an acceptable replacement for a 
standard enteric health program comprised of a coccidiostat, ROX and AGP. 
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